Product Information
ENILLORING VAGINAL RING is a generic product labeled by Xiromed LLC, priced at $46.3541 per EA under NDC 70700015691. Its NADAC has been published 147 times since Dec 13, 2023.
FDA first approved this application on Jun 29, 2023. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
.015; .12 mg/d; mg/d
Manufacturer
Xiromed LLCNDC
70700015691
Classification
Generic
Dosage Form
RING
Route
VAGINAL
Effective Date
9/23/2026
Active Ingredients
ETHINYL ESTRADIOL; ETONOGESTRELApproval Type
Generic (ANDA)
FDA Application
ANDA211157FDA Approved
6/29/2023
TE Code
AB
On Market Since
8/15/2023
Price Statistics
The NADAC for ENILLORING VAGINAL RING has been published 147 times since Dec 13, 2023, and over the history we have for it it has declined 45.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $46.3541 per EA |
|---|---|
| All-time high | $84.6419 (Dec 13, 2023) |
| All-time low | $42.5371 (Nov 20, 2024) |
| 52-week high | $50.5133 |
| 52-week low | $46.3541 |
| Median price | $50.0430 |
| Average price | $53.5036 |
| Largest weekly change | +30.7% (Aug 21, 2024) |
| Weeks tracked | 147 |
| Tracking since | Dec 13, 2023 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Etonogestrel and Ethinyl Estradiol Vaginal market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Xiromed LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Etonogestrel and Ethinyl Estradiol Vaginal market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Estrogen class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ENILLORING VAGINAL RING?
The current National Average Drug Acquisition Cost (NADAC) for ENILLORING VAGINAL RING, manufactured by Xiromed LLC, is $46.3541 per EA (NDC 70700015691), effective Sep 30, 2026.
How has the price of ENILLORING VAGINAL RING changed over time?
Over the history we have for it, the NADAC for ENILLORING VAGINAL RING has declined 45.2%. It has been tracked across 147 weekly CMS publications since Dec 13, 2023.
What are the highest and lowest recorded NADAC prices for ENILLORING VAGINAL RING?
Since Dec 13, 2023, the NADAC for ENILLORING VAGINAL RING has ranged from a low of $42.5371 (Nov 20, 2024) to a high of $84.6419 (Dec 13, 2023), with a median of $50.0430 per EA.
Are there cheaper alternatives to ENILLORING VAGINAL RING?
No other NADAC-published product currently shares the active ingredient and strength of ENILLORING VAGINAL RING in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures ENILLORING VAGINAL RING?
ENILLORING VAGINAL RING (NDC 70700015691) is labeled by Xiromed LLC, and CMS classifies it as a generic product.